Engineering iridoviruses: development of reverse genetics and virus rescue systems
Journal of Virology · 2025
DOI: 10.1128/jvi.01852-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2025. Verfasst von Daria Vladimirova und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institut für Virologie, Freie Universität Berlin, Berlin, Germany. Hauptthemen laut MEDLINE: Reverse Genetics, Ranavirus, Iridovirus, Genetic Engineering. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Freie Universität Berlin.
Abstract (Originalsprache)
Iridoviruses are a family of large DNA viruses that infect insects and poikilotherm vertebrates, including amphibians, reptiles, and fish. Notably, members of the genus Ranavirus cause mass mortality in fish and amphibians, threatening aquaculture and contributing to global amphibian decline. Despite their omnipresence and impact, key aspects of iridovirus biology remain unknown, largely due to the absence of reverse genetics systems. In this study, we developed, characterized, and utilized a reverse genetics system for frog virus 3 (FV3, Ranavirus rana1 ), one of the most widely studied iridoviruses. The rescued virus exhibits growth and phenotypic properties identical to those of the parental virus isolate. Furthermore, we established an alternative approach of virus reconstitution from genomic DNA, utilizing a heterologous iridovirus as a helper. This novel approach enables rapid and facile rescue of modified viruses from naked DNA. The reverse genetics and rescue systems described in this study will advance iridovirus research by facilitating efficient genetic modification of the virus genome in yeast or bacteria. This could clear the path to elucidating functions of virus genes and allow a much more detailed understanding of iridovirus biology. Moreover, owing to the promiscuous nature of FV3 with its ability to infect hosts from different classes of animals, the FV3 system has the potential to serve as a platform for the development of modified live vaccines for a variety of fish and amphibian species. IMPORTANCE Iridoviruses pose a substantial threat to aquaculture and global amphibian populations, yet research has been hindered by the lack of a reverse genetics system. In this study, we describe the development of the first such system for this virus family. We constructed a synthetic clone of frog virus 3 (FV3) that can be propagated and genetically manipulated in both yeast and bacteria, yielding a virus that has biological properties identical to the parental virus isolate. Furthermore, we developed a novel helper virus-based system for the rescue of FV3 from purified DNA. This system provides an essential tool for advancing our understanding of iridovirus biology and serves as a platform for the development of modified live virus vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut für Virologie, Freie Universität Berlin, Berlin, Germany.
- Department of Diagnostic Medicine and Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas, USA.
ORCID-Profile: Daria Vladimirova, Ji Yoon Kim, Dusan Kunec, Jakob Trimpert
Förderung
- Freie Universität Berlin
Zitieren
APA
Vladimirova, D., Kunecova, D., Nascimento, M., Kim, J. Y., Kunec, D., & Trimpert, J. (2025). Engineering iridoviruses: development of reverse genetics and virus rescue systems. Journal of Virology. https://doi.org/10.1128/jvi.01852-24
Vancouver
Vladimirova D, Kunecova D, Nascimento M, Kim JY, Kunec D, Trimpert J. Engineering iridoviruses: development of reverse genetics and virus rescue systems. Journal of Virology. 2025. doi:10.1128/jvi.01852-24
BibTeX
@article{Vladimirova2025,
author = {Vladimirova, Daria and Kunecova, Daniela and Nascimento, Mariana and Kim, Ji Yoon and Kunec, Dusan and Trimpert, Jakob},
title = {Engineering iridoviruses: development of reverse genetics and virus rescue systems},
journal = {Journal of Virology},
year = {2025},
doi = {10.1128/jvi.01852-24}
}
EUVIMED